1. Companion Diagnostics Market - Market Overview

2. Executive Summary

3. Companion Diagnostics Market - Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End user profiling

3.2.3. Patent Analysis

3.2.4. Top 5 Financials Analysis

4. Companion Diagnostics Market - Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Industry

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. Companion Diagnostics Market - Government Regulations

6. Companion Diagnostics Market - Strategic Analysis

6.1. Value Chain Analysis

6.2. Pricing Analysis

6.3. Opportunities Analysis

6.4. Product/Market Life Cycle Analysis

7. Companion Diagnostics Market - By Technology

7.1. Polymerase Chain Reaction (PCR)

7.2. Sequencing-based

7.3. In Situ Hybridization (ISH)

7.4. Immunohistochemistry (IHC)

7.5. Others

8. Companion Diagnostics Market - By Applications

8.1. Breast Cancer

8.2. Lung Cancer

8.3. Colorectal Cancer

8.4. Melanoma

8.5. Gastric Cancer

8.6. Others

9. Companion Diagnostics Market - By End Users

9.1. Pharmaceutical Companies

9.2. Reference Laboratries

9.3. CRO

9.4. Hospitals

9.5. Research Institutes

10. Companion Diagnostics Market - Geographic Analysis

10.1. Americas

10.2. Europe

10.3. APAC

10.4. ROW

11. Market Entropy

11.1. New Product Launches

11.2. M&As, Collaborations, JVs and Partnerships

12. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

12.1. Abbott Laboratories 

12.2. Advanced Cell Diagnostics Inc. 

12.3. Agilent Technologies, Inc.

12.4. Biomérieux

12.5. Biogenex Laboratories

12.6. Danaher Corporation

12.7. GE Healthcare

12.8. Myriad Genetics, Inc.

12.9. Qiagen N.V.

12.10. Roche Diagnostics

12.11. Thermo Fisher Scientific, Inc.

12.12. R-Biopharm AG

12.13. Cypher Genomics

12.14. Flagship Biosciences

12.15. Applied Proteomics

12.16. Ignyta, Inc.

12.17. Madison Vaccines, Inc.

12.18. Ventana Medical Systems, Inc.

"*Financials would be provided on a best efforts basis for private companies"

13. Appendix

13.1. Abbreviations

13.2. Sources

13.3. Research Methodology

13.4. Bibliography

13.5. Compilation of Expert Insights

13.6. Disclaimer